Global Recombinant Zoster Vaccine Market Growth 2022-2028
The global market for Recombinant Zoster Vaccine is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Recombinant Zoster Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Recombinant Zoster Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Recombinant Zoster Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Recombinant Zoster Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Recombinant Zoster Vaccine players cover GSK, Merck and Changchun Bcht Biotechnology. etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Recombinant Zoster Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Recombinant Zoster Vaccine market, with both quantitative and qualitative data, to help readers understand how the Recombinant Zoster Vaccine market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Recombinant Zoster Vaccine market and forecasts the market size by Type (Monovalent Vaccine and Combination Vaccine,), by Application (Above 50 Years Old and Below 50 Years Old.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Monovalent Vaccine
Combination Vaccine
Segmentation by application
Above 50 Years Old
Below 50 Years Old
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
GSK
Merck
Changchun Bcht Biotechnology
Chapter Introduction
Chapter 1: Scope of Recombinant Zoster Vaccine, Research Methodology, etc.
Chapter 2: Executive Summary, global Recombinant Zoster Vaccine market size (sales and revenue) and CAGR, Recombinant Zoster Vaccine market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Recombinant Zoster Vaccine sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Recombinant Zoster Vaccine sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Recombinant Zoster Vaccine market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including GSK, Merck and Changchun Bcht Biotechnology, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Recombinant Zoster Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Recombinant Zoster Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Recombinant Zoster Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Recombinant Zoster Vaccine Segment by Type
2.2.1 Monovalent Vaccine
2.2.2 Combination Vaccine
2.3 Recombinant Zoster Vaccine Sales by Type
2.3.1 Global Recombinant Zoster Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Recombinant Zoster Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Recombinant Zoster Vaccine Sale Price by Type (2017-2022)
2.4 Recombinant Zoster Vaccine Segment by Application
2.4.1 Above 50 Years Old
2.4.2 Below 50 Years Old
2.5 Recombinant Zoster Vaccine Sales by Application
2.5.1 Global Recombinant Zoster Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Recombinant Zoster Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Recombinant Zoster Vaccine Sale Price by Application (2017-2022)
3 Global Recombinant Zoster Vaccine by Company
3.1 Global Recombinant Zoster Vaccine Breakdown Data by Company
3.1.1 Global Recombinant Zoster Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Recombinant Zoster Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Recombinant Zoster Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Recombinant Zoster Vaccine Revenue by Company (2020-2022)
3.2.2 Global Recombinant Zoster Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Recombinant Zoster Vaccine Sale Price by Company
3.4 Key Manufacturers Recombinant Zoster Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant Zoster Vaccine Product Location Distribution
3.4.2 Players Recombinant Zoster Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Recombinant Zoster Vaccine by Geographic Region
4.1 World Historic Recombinant Zoster Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Recombinant Zoster Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Recombinant Zoster Vaccine Annual Revenue by Geographic Region
4.2 World Historic Recombinant Zoster Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Recombinant Zoster Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Recombinant Zoster Vaccine Annual Revenue by Country/Region
4.3 Americas Recombinant Zoster Vaccine Sales Growth
4.4 APAC Recombinant Zoster Vaccine Sales Growth
4.5 Europe Recombinant Zoster Vaccine Sales Growth
4.6 Middle East & Africa Recombinant Zoster Vaccine Sales Growth
5 Americas
5.1 Americas Recombinant Zoster Vaccine Sales by Country
5.1.1 Americas Recombinant Zoster Vaccine Sales by Country (2017-2022)
5.1.2 Americas Recombinant Zoster Vaccine Revenue by Country (2017-2022)
5.2 Americas Recombinant Zoster Vaccine Sales by Type
5.3 Americas Recombinant Zoster Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Zoster Vaccine Sales by Region
6.1.1 APAC Recombinant Zoster Vaccine Sales by Region (2017-2022)
6.1.2 APAC Recombinant Zoster Vaccine Revenue by Region (2017-2022)
6.2 APAC Recombinant Zoster Vaccine Sales by Type
6.3 APAC Recombinant Zoster Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Recombinant Zoster Vaccine by Country
7.1.1 Europe Recombinant Zoster Vaccine Sales by Country (2017-2022)
7.1.2 Europe Recombinant Zoster Vaccine Revenue by Country (2017-2022)
7.2 Europe Recombinant Zoster Vaccine Sales by Type
7.3 Europe Recombinant Zoster Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Recombinant Zoster Vaccine by Country
8.1.1 Middle East & Africa Recombinant Zoster Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Recombinant Zoster Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Recombinant Zoster Vaccine Sales by Type
8.3 Middle East & Africa Recombinant Zoster Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant Zoster Vaccine
10.3 Manufacturing Process Analysis of Recombinant Zoster Vaccine
10.4 Industry Chain Structure of Recombinant Zoster Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Recombinant Zoster Vaccine Distributors
11.3 Recombinant Zoster Vaccine Customer
12 World Forecast Review for Recombinant Zoster Vaccine by Geographic Region
12.1 Global Recombinant Zoster Vaccine Market Size Forecast by Region
12.1.1 Global Recombinant Zoster Vaccine Forecast by Region (2023-2028)
12.1.2 Global Recombinant Zoster Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Recombinant Zoster Vaccine Forecast by Type
12.7 Global Recombinant Zoster Vaccine Forecast by Application
13 Key Players Analysis
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Recombinant Zoster Vaccine Product Offered
13.1.3 GSK Recombinant Zoster Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Recombinant Zoster Vaccine Product Offered
13.2.3 Merck Recombinant Zoster Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Changchun Bcht Biotechnology
13.3.1 Changchun Bcht Biotechnology Company Information
13.3.2 Changchun Bcht Biotechnology Recombinant Zoster Vaccine Product Offered
13.3.3 Changchun Bcht Biotechnology Recombinant Zoster Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Changchun Bcht Biotechnology Main Business Overview
13.3.5 Changchun Bcht Biotechnology Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Recombinant Zoster Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Recombinant Zoster Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Monovalent Vaccine
Table 4. Major Players of Combination Vaccine
Table 5. Global Recombinant Zoster Vaccine Sales by Type (2017-2022) & (K Units)
Table 6. Global Recombinant Zoster Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global Recombinant Zoster Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Recombinant Zoster Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global Recombinant Zoster Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Recombinant Zoster Vaccine Sales by Application (2017-2022) & (K Units)
Table 11. Global Recombinant Zoster Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global Recombinant Zoster Vaccine Revenue by Application (2017-2022)
Table 13. Global Recombinant Zoster Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global Recombinant Zoster Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Recombinant Zoster Vaccine Sales by Company (2020-2022) & (K Units)
Table 16. Global Recombinant Zoster Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global Recombinant Zoster Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Recombinant Zoster Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global Recombinant Zoster Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Recombinant Zoster Vaccine Producing Area Distribution and Sales Area
Table 21. Players Recombinant Zoster Vaccine Products Offered
Table 22. Recombinant Zoster Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Recombinant Zoster Vaccine Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Recombinant Zoster Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Recombinant Zoster Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Recombinant Zoster Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Recombinant Zoster Vaccine Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Recombinant Zoster Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Recombinant Zoster Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Recombinant Zoster Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Recombinant Zoster Vaccine Sales by Country (2017-2022) & (K Units)
Table 34. Americas Recombinant Zoster Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas Recombinant Zoster Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Recombinant Zoster Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas Recombinant Zoster Vaccine Sales by Type (2017-2022) & (K Units)
Table 38. Americas Recombinant Zoster Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas Recombinant Zoster Vaccine Sales by Application (2017-2022) & (K Units)
Table 40. Americas Recombinant Zoster Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC Recombinant Zoster Vaccine Sales by Region (2017-2022) & (K Units)
Table 42. APAC Recombinant Zoster Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC Recombinant Zoster Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Recombinant Zoster Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC Recombinant Zoster Vaccine Sales by Type (2017-2022) & (K Units)
Table 46. APAC Recombinant Zoster Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC Recombinant Zoster Vaccine Sales by Application (2017-2022) & (K Units)
Table 48. APAC Recombinant Zoster Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe Recombinant Zoster Vaccine Sales by Country (2017-2022) & (K Units)
Table 50. Europe Recombinant Zoster Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe Recombinant Zoster Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Recombinant Zoster Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe Recombinant Zoster Vaccine Sales by Type (2017-2022) & (K Units)
Table 54. Europe Recombinant Zoster Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe Recombinant Zoster Vaccine Sales by Application (2017-2022) & (K Units)
Table 56. Europe Recombinant Zoster Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Recombinant Zoster Vaccine Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Recombinant Zoster Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Recombinant Zoster Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Recombinant Zoster Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Recombinant Zoster Vaccine Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Recombinant Zoster Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Recombinant Zoster Vaccine Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Recombinant Zoster Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Recombinant Zoster Vaccine
Table 66. Key Market Challenges & Risks of Recombinant Zoster Vaccine
Table 67. Key Industry Trends of Recombinant Zoster Vaccine
Table 68. Recombinant Zoster Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Recombinant Zoster Vaccine Distributors List
Table 71. Recombinant Zoster Vaccine Customer List
Table 72. Global Recombinant Zoster Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Recombinant Zoster Vaccine Sales Market Forecast by Region
Table 74. Global Recombinant Zoster Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Recombinant Zoster Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Recombinant Zoster Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Recombinant Zoster Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Recombinant Zoster Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Recombinant Zoster Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Recombinant Zoster Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Recombinant Zoster Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Recombinant Zoster Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Recombinant Zoster Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Recombinant Zoster Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Recombinant Zoster Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Recombinant Zoster Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Recombinant Zoster Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Recombinant Zoster Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Recombinant Zoster Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Recombinant Zoster Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Recombinant Zoster Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. GSK Basic Information, Recombinant Zoster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. GSK Recombinant Zoster Vaccine Product Offered
Table 94. GSK Recombinant Zoster Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. GSK Main Business
Table 96. GSK Latest Developments
Table 97. Merck Basic Information, Recombinant Zoster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Merck Recombinant Zoster Vaccine Product Offered
Table 99. Merck Recombinant Zoster Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Merck Main Business
Table 101. Merck Latest Developments
Table 102. Changchun Bcht Biotechnology Basic Information, Recombinant Zoster Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Changchun Bcht Biotechnology Recombinant Zoster Vaccine Product Offered
Table 104. Changchun Bcht Biotechnology Recombinant Zoster Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Changchun Bcht Biotechnology Main Business
Table 106. Changchun Bcht Biotechnology Latest Developments
List of Figures
Figure 1. Picture of Recombinant Zoster Vaccine
Figure 2. Recombinant Zoster Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant Zoster Vaccine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Recombinant Zoster Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Recombinant Zoster Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Monovalent Vaccine
Figure 10. Product Picture of Combination Vaccine
Figure 11. Global Recombinant Zoster Vaccine Sales Market Share by Type in 2021
Figure 12. Global Recombinant Zoster Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. Recombinant Zoster Vaccine Consumed in Above 50 Years Old
Figure 14. Global Recombinant Zoster Vaccine Market: Above 50 Years Old (2017-2022) & (K Units)
Figure 15. Recombinant Zoster Vaccine Consumed in Below 50 Years Old
Figure 16. Global Recombinant Zoster Vaccine Market: Below 50 Years Old (2017-2022) & (K Units)
Figure 17. Global Recombinant Zoster Vaccine Sales Market Share by Application (2017-2022)
Figure 18. Global Recombinant Zoster Vaccine Revenue Market Share by Application in 2021
Figure 19. Recombinant Zoster Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Recombinant Zoster Vaccine Revenue Market Share by Company in 2021
Figure 21. Global Recombinant Zoster Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Recombinant Zoster Vaccine Revenue Market Share by Geographic Region in 2021
Figure 23. Global Recombinant Zoster Vaccine Sales Market Share by Region (2017-2022)
Figure 24. Global Recombinant Zoster Vaccine Revenue Market Share by Country/Region in 2021
Figure 25. Americas Recombinant Zoster Vaccine Sales 2017-2022 (K Units)
Figure 26. Americas Recombinant Zoster Vaccine Revenue 2017-2022 ($ Millions)
Figure 27. APAC Recombinant Zoster Vaccine Sales 2017-2022 (K Units)
Figure 28. APAC Recombinant Zoster Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. Europe Recombinant Zoster Vaccine Sales 2017-2022 (K Units)
Figure 30. Europe Recombinant Zoster Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Recombinant Zoster Vaccine Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Recombinant Zoster Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Americas Recombinant Zoster Vaccine Sales Market Share by Country in 2021
Figure 34. Americas Recombinant Zoster Vaccine Revenue Market Share by Country in 2021
Figure 35. United States Recombinant Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Recombinant Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Recombinant Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Recombinant Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Recombinant Zoster Vaccine Sales Market Share by Region in 2021
Figure 40. APAC Recombinant Zoster Vaccine Revenue Market Share by Regions in 2021
Figure 41. China Recombinant Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Recombinant Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Recombinant Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Recombinant Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Recombinant Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Recombinant Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Recombinant Zoster Vaccine Sales Market Share by Country in 2021
Figure 48. Europe Recombinant Zoster Vaccine Revenue Market Share by Country in 2021
Figure 49. Germany Recombinant Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Recombinant Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Recombinant Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Recombinant Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Recombinant Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Recombinant Zoster Vaccine Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Recombinant Zoster Vaccine Revenue Market Share by Country in 2021
Figure 56. Egypt Recombinant Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Recombinant Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Recombinant Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Recombinant Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Recombinant Zoster Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Recombinant Zoster Vaccine in 2021
Figure 62. Manufacturing Process Analysis of Recombinant Zoster Vaccine
Figure 63. Industry Chain Structure of Recombinant Zoster Vaccine
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets